Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome

This study has been terminated.
(New sponsor, other treatments available)
Information provided by (Responsible Party):
Emergent Product Development Seattle LLC Identifier:
First received: August 8, 2005
Last updated: July 24, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)